HMGB1: The missing link between diabetes mellitus and heart failure

Basic Research in Cardiology

Volumn 105, Issue 6, 2010, Pages 805-820

  Volz, H Christian ^a   Seidel, Cathrin ^a   Laohachewin, Danai ^a   Kaya, Ziya ^a   Müller, Oliver J ^a   Pleger, Sven T ^a   Lasitschka, Felix ^a   Bianchi, Marco E ^b   Remppis, Andrew ^a   Bierhaus, Angelika ^a   Katus, Hugo A ^a   Andrassy, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Diabetes; Heart failure; HMGB1; Inflammation; Post myocardial infarction remodeling; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GLUCOSE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; RNA; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; FIBROBLAST; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TISSUE INJURY;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; GLUCOSE; HEART FAILURE; HMGB1 PROTEIN; INFLAMMATION MEDIATORS; INJECTIONS, INTRAPERITONEAL; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; NF-KAPPA B; RATS; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; VENTRICULAR REMODELING;

EID: 78649333667     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-010-0114-3     Document Type: Article

References (57)

1. E Abraham J Arcaroli A Carmody H Wang KJ Tracey 2000 HMG-1 as a mediator of acute lung inflammation J Immunol 165 2950 2954 10975801 1:CAS:528: DC%2BD3cXmslyns7g%3D
2. S Akira S Uematsu O Takeuchi 2006 Pathogen recognition and innate immunity Cell 124 783 801 10.1016/j.cell.2006.02.015 16497588 1:CAS:528:DC%2BD28Xit1Kltb8%3D (Pubitemid 43261452)
3. U Andersson H Wang K Palmblad AC Aveberger O Bloom H Erlandsson-Harris A Janson R Kokkola M Zhang H Yang KJ Tracey 2000 High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes J Exp Med 192 565 570 10.1084/jem.192.4.565 10952726 1:CAS:528:DC%2BD3cXlvFemsL0%3D (Pubitemid 30666257)
4. M Andrassy J Igwe F Autschbach C Volz A Remppis MF Neurath E Schleicher PM Humpert T Wendt B Liliensiek M Morcos S Schiekofer K Thiele J Chen R Kientsch-Engel AM Schmidt W Stremmel DM Stern HA Katus PP Nawroth A Bierhaus 2006 Posttranslationally modified proteins as mediators of sustained intestinal inflammation Am J Pathol 169 1223 1237 10.2353/ajpath.2006.050713 17003481 1:CAS:528:DC%2BD28XhtFeitLjL (Pubitemid 351194359)
5. M Andrassy HC Volz JC Igwe B Funke SN Eichberger Z Kaya S Buss F Autschbach ST Pleger IK Lukic F Bea SE Hardt PM Humpert ME Bianchi H Mairbaurl PP Nawroth A Remppis HA Katus A Bierhaus 2008 High-mobility group box-1 in ischemia-reperfusion injury of the heart Circulation 117 3216 3226 10.1161/CIRCULATIONAHA.108.769331 18574060 1:CAS:528:DC%2BD1cXnt1ehs7g%3D
6. A Bierhaus KM Haslbeck PM Humpert B Liliensiek T Dehmer M Morcos AA Sayed M Andrassy S Schiekofer JG Schneider JB Schulz D Heuss B Neundorfer S Dierl J Huber H Tritschler AM Schmidt M Schwaninger HU Haering E Schleicher M Kasper DM Stern B Arnold PP Nawroth 2004 Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily J Clin Invest 114 1741 1751 15599399 1:CAS:528:DC%2BD2cXhtFaiur7L
7. A Bierhaus PM Humpert M Morcos T Wendt T Chavakis B Arnold DM Stern PP Nawroth 2005 Understanding RAGE, the receptor for advanced glycation end products J Mol Med 83 876 886 10.1007/s00109-005-0688-7 16133426 1:CAS:528:DC%2BD2MXht1SksbjP (Pubitemid 41598688)
8. A Bierhaus S Schiekofer M Schwaninger M Andrassy PM Humpert J Chen M Hong T Luther T Henle I Kloting M Morcos M Hofmann H Tritschler B Weigle M Kasper M Smith G Perry AM Schmidt DM Stern HU Haring E Schleicher PP Nawroth 2001 Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB Diabetes 50 2792 2808 10.2337/diabetes.50.12.2792 11723063 1:CAS:528:DC%2BD3MXovVOhsrk%3D
9. B Bozkurt SB Kribbs FJ Clubb Jr LH Michael VV Didenko PJ Hornsby Y Seta H Oral FG Spinale DL Mann 1998 Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats Circulation 97 1382 1391 9577950 1:CAS:528: DyaK1cXis1KqtL0%3D
10. A Bruchfeld AR Qureshi B Lindholm P Barany L Yang P Stenvinkel KJ Tracey 2008 High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD) Mol Med 14 109 115 10.2119/2007-00107.Bruchfeld 18317568 1:CAS:528:DC%2BD1cXksVegu7s%3D (Pubitemid 351481841)
11. T Calandra B Echtenacher DL Roy J Pugin CN Metz L Hultner D Heumann D Mannel R Bucala MP Glauser 2000 Protection from septic shock by neutralization of macrophage migration inhibitory factor Nat Med 6 164 170 10.1038/72262 10655104 1:CAS:528:DC%2BD3cXosFyqtQ%3D%3D (Pubitemid 30082360)
12. B Chandrasekar GL Freeman 1997 Induction of nuclear factor kappaB and activation protein 1 in postischemic myocardium FEBS Lett 401 30 34 10.1016/S0014-5793(96)01426-3 9003800 1:CAS:528:DyaK2sXns1Shug%3D%3D (Pubitemid 27051252)
13. E Chorianopoulos T Heger M Lutz D Frank F Bea HA Katus N Frey 2010 FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK Basic Res Cardiol 105 301 313 10.1007/s00395-009-0046-y 19629561 1:CAS:528:DC%2BC3cXnvFWrsg%3D%3D
14. H Dorge R Schulz S Belosjorow H Post A van de Sand I Konietzka S Frede T Hartung J Vinten-Johansen KA Youker ML Entman R Erbel G Heusch 2002 Coronary microembolization: the role of TNF-alpha in contractile dysfunction J Mol Cell Cardiol 34 51 62 10.1006/jmcc.2001.1489 11812164 1:CAS:528: DC%2BD38XntlOhuw%3D%3D (Pubitemid 34146395)
15. IE Dumitriu P Baruah AA Manfredi ME Bianchi P Rovere-Querini 2005 HMGB1: guiding immunity from within Trends Immunol 26 381 387 10.1016/j.it.2005.04.009 15978523 1:CAS:528:DC%2BD2MXlsFCrt7k%3D (Pubitemid 40835844)
16. IE Dumitriu P Baruah B Valentinis RE Voll M Herrmann PP Nawroth B Arnold ME Bianchi AA Manfredi P Rovere-Querini 2005 Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products J Immunol 174 7506 7515 15944249 1:CAS:528: DC%2BD2MXkvVOmt74%3D
17. S Frantz J Bauersachs G Ertl 2009 Post-infarct remodelling: contribution of wound healing and inflammation Cardiovasc Res 81 474 481 10.1093/cvr/cvn292 18977766 1:CAS:528:DC%2BD1MXhtlKit7c%3D
18. S Frantz D Fraccarollo H Wagner TM Behr P Jung CE Angermann G Ertl J Bauersachs 2003 Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure Cardiovasc Res 57 749 756 10.1016/S0008-6363(02)00723-X 12618236 1:CAS:528:DC%2BD3sXhs1ehtrw%3D (Pubitemid 36254868)
19. C Gebhardt A Riehl M Durchdewald J Nemeth G Furstenberger K Muller-Decker A Enk B Arnold A Bierhaus PP Nawroth J Hess P Angel 2008 RAGE signaling sustains inflammation and promotes tumor development J Exp Med 205 275 285 10.1084/jem.20070679 18208974 1:CAS:528:DC%2BD1cXisVeht7w%3D (Pubitemid 351281593)
20. S Goser M Andrassy SJ Buss F Leuschner CH Volz R Ottl S Zittrich N Blaudeck SE Hardt G Pfitzer NR Rose HA Katus Z Kaya 2006 Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium Circulation 114 1693 1702 10.1161/CIRCULATIONAHA.106.635664 17015788 1:CAS:528:DC%2BD28XhtVKrt7vO (Pubitemid 44607117)
21. SM Haffner S Lehto T Ronnemaa K Pyorala M Laakso 1998 Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 229 234 10.1056/NEJM199807233390404 9673301 1:STN:280:DyaK1czivVKgsg%3D%3D (Pubitemid 28350165)
22. SE Hardt YJ Geng O Montagne K Asai C Hong GP Yang SP Bishop SJ Kim DE Vatner CE Seidman JG Seidman CJ Homcy SF Vatner 2002 Accelerated cardiomyopathy in mice with overexpression of cardiac G(s)alpha and a missense mutation in the alpha-myosin heavy chain Circulation 105 614 620 10.1161/hc0502.103012 11827928 1:CAS:528:DC%2BD38XhslGgsLc%3D (Pubitemid 34123437)
23. FM Heidrich K Zhang M Estrada Y Huang FJ Giordano BE Ehrlich 2008 Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes Circ Res 102 1230 1238 10.1161/CIRCRESAHA.107.166033 18420944 1:CAS:528:DC%2BD1cXlslGlt70%3D
24. MA Hofmann S Drury C Fu W Qu A Taguchi Y Lu C Avila N Kambham A Bierhaus P Nawroth MF Neurath T Slattery D Beach J McClary M Nagashima J Morser D Stern AM Schmidt 1999 RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 889 901 10.1016/S0092-8674(00)80801-6 10399917 1:CAS:528:DyaK1MXktlCltrc%3D (Pubitemid 29375048)
25. O Hori J Brett T Slattery R Cao J Zhang JX Chen M Nagashima ER Lundh S Vijay D Nitecki, et al. 1995 The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system J Biol Chem 270 25752 25761 10.1074/jbc.270.43.25752 7592757 1:CAS:528: DyaK2MXovFyks7s%3D
26. GS Hotamisligil NS Shargill BM Spiegelman 1993 Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 87 91 10.1126/science.7678183 7678183 1:CAS:528:DyaK3sXnvFaitw%3D%3D
27. Y Huang H Yin J Han B Huang J Xu F Zheng Z Tan M Fang L Rui D Chen S Wang X Zheng CY Wang F Gong 2007 Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection Am J Transplant 7 799 808 10.1111/j.1600-6143.2007.01734.x 17331117 1:CAS:528:DC%2BD2sXltFOjs70%3D (Pubitemid 46481209)
28. SH Ihm K Chang HY Kim SH Baek HJ Youn KB Seung JH Kim 2010 Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor Basic Res Cardiol 105 399 407 10.1007/s00395-009-0071-x 19902320 1:CAS:528:DC%2BC3cXis1yhsLY%3D
29. A Ilercil RB Devereux MJ Roman M Paranicas MJ O'Grady TK Welty DC Robbins RR Fabsitz BV Howard ET Lee 2001 Relationship of impaired glucose tolerance to left ventricular structure and function: the strong heart study Am Heart J 141 992 998 10.1067/mhj.2001.115302 11376315 1:STN:280:DC%2BD3Mzhs1Wmsw%3D%3D (Pubitemid 32477012)
30. WB Kannel DL McGee 1979 Diabetes and cardiovascular disease. The Framingham study Jama 241 2035 2038 10.1001/jama.241.19.2035 430798 1:STN:280:DyaE1M7lsVCksg%3D%3D (Pubitemid 9228506)
31. T Kohno T Anzai K Naito T Miyasho M Okamoto H Yokota S Yamada Y Maekawa T Takahashi T Yoshikawa A Ishizaka S Ogawa 2009 Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling Cardiovasc Res 81 565 573 10.1093/cvr/cvn291 18984601 1:CAS:528: DC%2BD1MXhtlKitbs%3D
32. R Kokkola E Sundberg AK Ulfgren K Palmblad J Li H Wang L Ulloa H Yang XJ Yan R Furie N Chiorazzi KJ Tracey U Andersson HE Harris 2002 High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis Arthritis Rheum 46 2598 2603 10.1002/art.10540 12384917 1:CAS:528: DC%2BD38XovVWitrw%3D (Pubitemid 36118922)
33. S Li S Zhong K Zeng Y Luo F Zhang X Sun L Chen 2010 Blockade of NF-kappaB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats Basic Res Cardiol 105 139 150 10.1007/s00395-009-0067-6 19823892 1:CAS:528:DC%2BD1MXhsFanu7nJ
34. B Liliensiek MA Weigand A Bierhaus W Nicklas M Kasper S Hofer J Plachky HJ Grone FC Kurschus AM Schmidt SD Yan E Martin E Schleicher DM Stern GG Hammerling PP Nawroth B Arnold 2004 Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J Clin Invest 113 1641 1650 15173891 1:CAS:528:DC%2BD2cXkvVOqtrY%3D
35. F Limana A Germani A Zacheo J Kajstura A Di Carlo G Borsellino O Leoni R Palumbo L Battistini R Rastaldo S Muller G Pompilio P Anversa ME Bianchi MC Capogrossi 2005 Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation Circ Res 97 e73 e83 10.1161/01.RES.0000186276.06104.04 16166556 1:CAS:528:DC%2BD2MXhtVymt7bN
36. DL Mann 2002 Inflammatory mediators and the failing heart: past, present, and the foreseeable future Circ Res 91 988 998 10.1161/01.RES.0000043825.01705. 1B 12456484 1:CAS:528:DC%2BD38XoslOqt7o%3D (Pubitemid 35416635)
37. MC Michel Y Li G Heusch 2001 Mitogen-activated protein kinases in the heart Naunyn Schmiedebergs Arch Pharmacol 363 245 266 10.1007/s002100000363 11284439 1:CAS:528:DC%2BD3MXhtl2qtbw%3D (Pubitemid 32186523)
38. S Muller ME Bianchi S Knapp 2001 Thermodynamics of HMGB1 interaction with duplex DNA Biochemistry 40 10254 10261 10.1021/bi0100900 11513603 1:CAS:528:DC%2BD3MXlsFygsbk%3D (Pubitemid 32800132)
39. M Nian P Lee N Khaper P Liu 2004 Inflammatory cytokines and postmyocardial infarction remodeling Circ Res 94 1543 1553 10.1161/01.RES. 0000130526.20854.fa 15217919 1:CAS:528:DC%2BD2cXlvVSgtLo%3D (Pubitemid 38856961)
40. R Palumbo M Sampaolesi F De Marchis R Tonlorenzi S Colombetti A Mondino G Cossu ME Bianchi 2004 Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation J Cell Biol 164 441 449 10.1083/jcb.200304135 14744997 1:CAS:528:DC%2BD2cXhtVahsrg%3D (Pubitemid 38174771)
41. P Rovere-Querini A Capobianco P Scaffidi B Valentinis F Catalanotti M Giazzon IE Dumitriu S Muller M Iannacone C Traversari ME Bianchi AA Manfredi 2004 HMGB1 is an endogenous immune adjuvant released by necrotic cells EMBO Rep 5 825 830 10.1038/sj.embor.7400205 15272298 1:CAS:528:DC%2BD2cXmtFOhur8%3D (Pubitemid 39199174)
42. AM Schmidt SD Yan SF Yan DM Stern 2001 The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J Clin Invest 108 949 955 11581294 1:CAS:528:DC%2BD3MXnt1Cku7k%3D
43. M Shimizu K Umeda N Sugihara H Yoshio H Ino R Takeda Y Okada I Nakanishi 1993 Collagen remodelling in myocardia of patients with diabetes J Clin Pathol 46 32 36 10.1136/jcp.46.1.32 7679418 1:STN:280:DyaK3s7mtlequg%3D%3D
44. A Skyschally P Gres S Hoffmann M Haude R Erbel R Schulz G Heusch 2007 Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction Circ Res 100 140 146 10.1161/01.RES.0000255031.15793.86 17170366 1:CAS:528:DC%2BD28XhtlGiurnM (Pubitemid 46066782)
45. AD Struthers AD Morris 2002 Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths Lancet 359 1430 1432 10.1016/S0140-6736(02)08358-7 11978359 (Pubitemid 34442390)
46. SV Subramanian RJ Kelm JA Polikandriotis CG Orosz AR Strauch 2002 Reprogramming of vascular smooth muscle alpha-actin gene expression as an early indicator of dysfunctional remodeling following heart transplant Cardiovasc Res 54 539 548 10.1016/S0008-6363(02)00270-5 12031699 1:CAS:528:DC%2BD38XjvVSgur0%3D (Pubitemid 34595412)
47. K Takahashi S Fukushima K Yamahara K Yashiro Y Shintani SR Coppen HK Salem SW Brouilette MH Yacoub K Suzuki 2008 Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart Circulation 118 S106 S114 10.1161/CIRCULATIONAHA.107.757443 18824741
48. M Thielmann H Dorge C Martin S Belosjorow U Schwanke A van De Sand I Konietzka A Buchert A Kruger R Schulz G Heusch 2002 Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine Circ Res 90 807 813 10.1161/01.RES.0000014451.75415.36 11964374 1:CAS:528:DC%2BD38Xjt1Kqt7g%3D (Pubitemid 34633897)
49. J Tian AM Avalos SY Mao B Chen K Senthil H Wu P Parroche S Drabic D Golenbock C Sirois J Hua LL An L Audoly G La Rosa A Bierhaus P Naworth A Marshak-Rothstein MK Crow KA Fitzgerald E Latz PA Kiener AJ Coyle 2007 Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE Nat Immunol 8 487 496 10.1038/ni1457 17417641 1:CAS:528:DC%2BD2sXkt1Khtro%3D (Pubitemid 46605917)
50. C Tschope T Walther F Escher F Spillmann J Du C Altmann I Schimke M Bader CF Sanchez-Ferrer HP Schultheiss M Noutsias 2005 Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy Faseb J 19 2057 2059 16129698
51. A Tsung R Sahai H Tanaka A Nakao MP Fink MT Lotze H Yang J Li KJ Tracey DA Geller TR Billiar 2005 The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion J Exp Med 201 1135 1143 10.1084/jem.20042614 15795240 1:CAS:528:DC%2BD2MXjtFWls7s%3D (Pubitemid 40524681)
52. S Van Linthout U Seeland A Riad O Eckhardt M Hohl N Dhayat U Richter JW Fischer M Bohm M Pauschinger HP Schultheiss C Tschope 2008 Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy Basic Res Cardiol 103 319 327 10.1007/s00395-008-0715-2 18347835 1:CAS:528:DC%2BD1cXptVWjuro%3D
53. H Wang O Bloom M Zhang JM Vishnubhakat M Ombrellino J Che A Frazier H Yang S Ivanova L Borovikova KR Manogue E Faist E Abraham J Andersson U Andersson PE Molina NN Abumrad A Sama KJ Tracey 1999 HMG-1 as a late mediator of endotoxin lethality in mice Science 285 248 251 10.1126/science.285.5425.248 10398600 1:CAS:528:DyaK1MXks1Sjtb0%3D (Pubitemid 29329996)
54. D Westermann S Van Linthout S Dhayat N Dhayat F Escher C Bucker-Gartner F Spillmann M Noutsias A Riad HP Schultheiss C Tschope 2007 Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy Diabetes 56 1834 1841 10.2337/db06-1662 17473225 1:CAS:528:DC%2BD2sXnvVWju7s%3D (Pubitemid 47025453)
55. D Westermann S Van Linthout S Dhayat N Dhayat A Schmidt M Noutsias XY Song F Spillmann A Riad HP Schultheiss C Tschope 2007 Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy Basic Res Cardiol 102 500 507 10.1007/s00395-007-0673-0 17909696 1:CAS:528:DC%2BD2sXhtlCnsrnO (Pubitemid 47578394)
56. Xu H, Su Z, Wu J, Yang M, Penninger JM, Martin CM, Kvietys PR, Rui T (2009) The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/Phosphatidylinositol 3-Kinase {gamma} Pathway. J Immunol
57. H Yang M Ochani J Li X Qiang M Tanovic HE Harris SM Susarla L Ulloa H Wang R DiRaimo CJ Czura H Wang J Roth HS Warren MP Fink MJ Fenton U Andersson KJ Tracey 2004 Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proc Natl Acad Sci USA 101 296 301 10.1073/pnas.2434651100 14695889 1:CAS:528:DC%2BD2cXjvFamtA%3D%3D (Pubitemid 38084244)